Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $179,734 | $181,740 | $159,081 | $145,789 |
| - Cash | $45,471 | $29,650 | $24,257 | $32,830 |
| + Debt | $230,983 | $202,356 | $173,065 | $144,128 |
| Enterprise Value | $365,246 | $354,446 | $307,889 | $257,087 |
| Revenue | $259,594 | $227,934 | $208,859 | $165,615 |
| % Growth | 13.9% | 9.1% | 26.1% | – |
| Gross Profit | $94,729 | $81,383 | $72,714 | $70,186 |
| % Margin | 36.5% | 35.7% | 34.8% | 42.4% |
| EBITDA | $48,056 | $43,294 | $24,924 | $29,492 |
| % Margin | 18.5% | 19% | 11.9% | 17.8% |
| Net Income | $18,986 | $16,173 | $2,201 | $15,914 |
| % Margin | 7.3% | 7.1% | 1.1% | 9.6% |
| EPS Diluted | 385.71 | 328.59 | 44.72 | 316.19 |
| % Growth | 17.4% | 634.8% | -85.9% | – |
| Operating Cash Flow | $23,401 | $8,212 | $2,544 | $22,129 |
| Capital Expenditures | -$31,223 | -$39,325 | -$30,469 | -$13,576 |
| Free Cash Flow | -$7,822 | -$31,113 | -$27,925 | $8,553 |